Tendencia de publicación de ensayos clínicos con resultados negativos fnanciados por industrias farmacéuticas durante el periodo 2007-2012

Translated title of the contribution: Publication trend of clinical trials with negative results funded by pharmaceutical industries for the 2007-2012 period

Evert A. Jiménez-Cotes, Laura Mejía-Cardona, Jorge H. Donado-Gómez

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objective: To evaluate the results of clinical trials financed by the pharmaceutical industries during the period 2007-2012 in a general medical journal. Materials and methods: We performed an observational cross sectional study where originals clinical trials financed by the pharmaceutical industry published between 2007 and 2012 in the journal The New England Journal of Medicine (http://www.nejm.org) were reviewed. Trend Chi2 test was used to evaluate the results of studies over the years. A database was created with different variables, identifying the number of publications and the period of greater publishing negatives studies, as well as the medical specialty and pharmaceutical industry funding. Results: 321 clinical trials were analyzed. The Odds Ratio was calculated for each year evaluated, finding a Chi2 of linear trend in negatives studies of 2.91 with value p 0.08 and positive studies of 1.16 with value p 0.28. It was found that in the period 2007-2009 123 studies were published, 40 % of which presented negative results; unlike the 2010-2012 period in which 198 clinical trials where published, 142 of them, showed positive results, OR 1.68, 95 % CI (1.02-2.78) value p 0.03. The highest figures of negative results were published in 2007: 44.7 %. Conclusions: A progressive decrease in the number of publications with annual general negative results has been observed. A statistically significant difference in the publication of negative studies per year was not found between the periods 2007-2012. The medical specialty that showed the largest number of total and negative publications in both periods was cardiology. The pharmaceutical industry that sponsored most total clinical trials with negative results in both periods did so through Merck, Glaxo SmithKline, and Sanofi-Aventis. 50 % of neurology publications showed negative results.

Translated title of the contributionPublication trend of clinical trials with negative results funded by pharmaceutical industries for the 2007-2012 period
Original languageSpanish
Pages (from-to)55-62
Number of pages8
JournalRevista Ciencias de la Salud
Volume13
Issue number1
DOIs
StatePublished - 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2014 (publisher). All Rights reserved.

Fingerprint

Dive into the research topics of 'Publication trend of clinical trials with negative results funded by pharmaceutical industries for the 2007-2012 period'. Together they form a unique fingerprint.

Cite this